The intestinal bioavailability of vaccenic acid and activation of peroxisome proliferator‐activated receptor‐α and ‐γ in a rodent model of dyslipidemia and the metabolic syndrome
- 20 June 2012
- journal article
- research article
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 56 (8) , 1234-1246
Abstract
Scope: Evidence suggests a neutral to beneficial role of certain trans fatty acids (TFA) from natural ruminant sources. Trans11–18:1 (vaccenic acid, VA), the most predominant ruminant TFA and a precursor to conjugated linoleic acid, has been shown to improve atherogenic dyslipidemia and symptoms of hepatic steatosis in animal models. The objective of this study was to assess the intestinal bioavailability of various VA sources including synthetic free fatty acid (FFA) and natural ruminant triglyceride forms, as well as the mechanistic pathways that mediate VA's bioactivity.Methods and results: VA acts as a partial agonist to both peroxisome proliferator‐activated receptors (PPAR)‐α and PPAR‐γ in vitro, with similar affinity compared to commonly known PPAR agonists. It was further confirmed that VA at 30 and 100 μM concentrations suppressed cardiomyocyte hypertrophy vitro in a PPAR‐α‐ and PPAR‐γ‐dependent manner. In vivo, feeding of VA (1%, w/w) resulted in increased mRNA and protein expression of PPAR‐γ in the mucosa of JCR:LA‐cp rats, a model of the metabolic syndrome (p < 0.01 and p < 0.05, respectively) compared to control. In addition, VA from a triglyceride source had greater intestinal bioavailability in vivo compared to VA provided in an FFA form (p < 0.01).Conclusion: The activation of PPAR‐α‐ and PPAR‐γ‐dependent pathways provides a mechanistic explanation of how VA improves blood lipids and related metabolic disorders during conditions of hyperlipidemia. This report also supports the consideration of differential reporting of industrially produced versus natural TFA on food nutrient labels.Keywords
This publication has 42 references indexed in Scilit:
- Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studiesBMJ, 2011
- Increased hypolipidemic benefits of cis-9, trans-11 conjugated linoleic acid in combination with trans-11 vaccenic acid in a rodent model of the metabolic syndrome, the JCR:LA-cp ratNutrition & Metabolism, 2010
- Regulatory enzymes of mitochondrial β‐oxidation as targets for treatment of the metabolic syndromeObesity Reviews, 2010
- Vaccenic and Elaidic Acid Modify Plasma and Splenocyte Membrane Phospholipids and Mitogen-Stimulated Cytokine Production in Obese Insulin Resistant JCR: LA-cp RatsNutrients, 2010
- PPARα: Energy Combustion, Hypolipidemia, Inflammation and CancerNuclear Receptor Signaling, 2010
- Trans-11 Vaccenic Acid Reduces Hepatic Lipogenesis and Chylomicron Secretion in JCR:LA-cp RatsThe Journal of Nutrition, 2009
- Peroxisome Proliferator–Activated Receptors as Transcriptional Nodal Points and Therapeutic TargetsCirculation, 2007
- Endothelin-1–Induced Cardiac Hypertrophy Is Inhibited by Activation of Peroxisome Proliferator–Activated Receptor-α Partly Via Blockade of c-Jun NH 2 -Terminal Kinase PathwayCirculation, 2004
- Inhibition of Atherosclerosis and Myocardial Lesions in the JCR:LA-cp Rat by β,β′-Tetramethylhexadecanedioic Acid (MEDICA 16)Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Endothelin stimulates hypertrophy and contractility of neonatal rat cardiac myocytes in a serum‐free mediumFEBS Letters, 1990